CoinStats logo
Injective

Injective

INJ

Injective (INJ) News Today: Why INJ Is Down – 16 November 2026

Ask CoinStats AI
Price
$6.84
down 0.43%24h
7d change
down 17.15%
up 0%30d
Market cap
$684.35M
Rank #110
24h volume
$71.94M
10.5% of market cap
All-time high
$52.62
87% below
On this page

What is the latest Injective (INJ) news today?

Injective news today centers on governance activity rather than a single breaking announcement. INJ traded at $6.88, down 1.11% over 24 hours, and no new development from the past day has been confirmed.

Veyra mainnet upgrade vote

Injective opened voting on its Veyra mainnet upgrade, a proposal that brings institutional-grade real-world asset infrastructure to the network. Reports say more than 99% of participating stakers support the upgrade, but voting was not yet complete. Timing differs between outlets. One summary states that voting was scheduled to close on 16 November, with the upgrade expected around 18 November if approved. Because the schedule has been reported inconsistently, the closing and activation dates remain unconfirmed. A later phase, described as a finance-markets upgrade, is reportedly slated for 24 November 2026 and targets cross-chain access, RFQ trading and atomic swaps, with delivery still dependent on governance.

Canary's staked INJ ETF

The Canary Staked INJ ETF, ticker INJC, is now trading on Nasdaq. The launch was announced on Nov. 06, 2026, and Canary Capital listed a staked spot exchange-traded fund holding Injective on the Nasdaq on November 5. The issuer describes it as the first U.S. product of this kind. The fund reached $16.12 million in net assets during its first two trading sessions. Its structure calls for staking most of its holdings, with at least 90 percent of its INJ holdings allocated to staking, and it carries a total annual fee of 1.10 percent. Custody sits with a trust bank affiliated with BitGo. The prospectus projects a yield of about 6.8%, but it includes a caveat: if the staked share moves toward the network's 60% target, the reward rate would fall sharply.

Injective news today: what to watch

Neither item is a new development from the past 24 to 48 hours. The ETF launch dates to early November, and the Veyra vote is still open. The next concrete markers are the Veyra vote outcome and any activation announcement tied to it. Investors should also track whether the ETF's early asset base holds, since the fund's first two sessions set the initial benchmark for institutional demand.

Why is Injective (INJ) price down today?

Injective price today is $6.88, down 1.11% over the last 24 hours. The daily move is modest. The larger pressure is over the past week, with the token down 15.75% over seven days. No single confirmed catalyst explains today's decline, so the move reads as continued selling on a weak trend.

Derivatives Positioning

Leveraged demand appears to be cooling. One recent report noted that futures Open Interest drops 4%, and sellers dominate in the near term. The same coverage described investor participation in Injective's derivatives market has weakened considerably over the past several weeks.

Broader Market and Governance Backdrop

Injective is not moving in isolation. One analysis said the token continues to face broader cryptocurrency market weakness. Governance is also unresolved: the Veyra upgrade has broad support but has not yet reached quorum. The upgrade adds institutional trading tools without changing INJ's supply or staking rewards, so it is not a supply event. Its pending status still leaves a question open for near-term sentiment.

Trading Activity and Market Size

The token has a market capitalization of $688.17M (rank #111) and a 24h trading volume of $96.41M. The price is 86.92% below its all-time high of $52.62. The 1-hour change of +1.20% suggests the selling has slowed in the most recent hour, although it has not reversed the daily decline.

Technical Levels

Price action has broken through several support levels that were cited earlier in the month. One analysis placed the Fibonacci support at $7.33, and noted that if $7.33 breaks on a closing basis, the next support sits at $6.69. The price is now below $7.33, which puts $6.69 in focus. Another technical view noted that price trades under the 20 EMA at $7.675 and the 50-day at $7.526, while it holds above the 100 EMA at $6.937 and the 200 EMA at $6.298. Those moving averages mark the overhead resistance zone and the lower trend support.

Outlook

The near-term structure is defined by whether INJ holds the $6.69 area. A sustained close below that level would put the lower moving averages in play, while a recovery above the 20-day EMA would ease the bearish read. Traders should watch derivatives open interest and the Veyra vote for the next directional signal.

What is the Injective (INJ) market sentiment today?

Injective market sentiment is mixed. Derivatives positioning leans cautious, while community and ecosystem discussion on X remains constructive.

Derivatives and Positioning

Funding has been slightly negative at -0.0135% per 8-hour period, which the derivatives data labels bearish. The 14-day average of 0.0031% is close to neutral, so leverage imbalance is limited. Open interest has fallen to $136.00M, down 27.77% over 30 days from a high of $215.91M, which points to waning participation. Binance long/short accounts show 50.5% long, but the recent trend has moved toward shorts, and the 14-day average long share was 56.9%.

Liquidations

Over the past 24 hours, roughly $140K was liquidated, and 99.4% of that was long positions. This suggests overleveraged longs were the main casualties of the latest decline. The largest single liquidation in the 14-day window reached $1.82M on November 14.

Market-Wide Mood

The Fear & Greed Index stands at 11, in Extreme Fear, with a 14-day average of 27. Sentiment fell 19 points over seven days as Bitcoin declined, so Injective's mood is closely tied to broader risk aversion.

Social and Community Sentiment

Posts on X from November 9 to 16 were predominantly bullish, centered on the fifth mainnet anniversary and the Veyra upgrade proposal, which is open for staker voting and targeted for November 24. Supporters cited more than $12B in annual trading volume and a record 58.8M INJ staked. Reported integrations, including an Anthropic pre-IPO market and a Robinhood sweepstakes, appear in social posts and are not independently confirmed. Bearish commentary was scarce in the sampled posts, so social data likely overrepresents supporters.

Recent Sentiment Shifts

  • Negative, November 9: Block production halted for the second time in roughly ten weeks, and Upbit and Bithumb suspended INJ deposits and withdrawals. Cryptopolitan report
  • Positive, early November: The Canary Staked INJ ETF (INJC) began trading on Nasdaq, adding a regulated US access point with staking exposure. Coin Gabbar report
  • Mixed, November 13–15: Veyra governance held 70.91% yes votes but had not reached quorum in the November 14 update. Commentary has questioned whether the upgrade can offset selling pressure. Coin Gabbar analysis
  • Positive, November 14: Injective's USDC migration is advancing, with more than $80M still pending transfer across Cosmos and dYdX. Coin Gabbar report

Outlook

Trading data currently points to caution: weakening open interest, slightly negative funding, and a Fear & Greed reading in Extreme Fear. Social sentiment remains optimistic. The Veyra activation on November 24 and whether quorum is reached are the key events that could shift positioning.

What are the key Injective (INJ) support and resistance levels today?

Injective support and resistance levels sit below and just above INJ's $6.88 price, after a 7-day decline of 15.75%. The token traded above $8 in mid-November, so the current range is a retracement from that zone.

Key Levels

Resistance

  • $7.19: the rising daily trendline that Injective continues to trade above an ascending support trendline around $7.19. Spot now sits below it, so a retest from underneath would be resistance.
  • $7.55: the 50-day EMA, which represents the first obstacle on a recovery.
  • $7.81–$8.15: the daily EMA20 at $7.81, with an hourly close above $8.15 needed to confirm a breakout.
  • $8.35: a horizontal resistance level that limited Injective's gains during the previous week.

Support

  • $6.71: If INJ breaks decisively below the trendline, the next significant support stands at $6.71.
  • $6.55–$6.60: Holding the $6.55–$6.60 support area could help limit further downside pressure.
  • $6.07–$6.27: the long-term EMA zone. The daily EMA200 was $6.07 in the November 13 reading, while another analysis placed it near $6.27.

Indicators

  • RSI: As of November 13, Daily RSI is 44.7 and falling, which is neutral with downward momentum.
  • MACD: The daily MACD histogram has also fallen through zero into negative territory.
  • Moving averages: Price is above daily EMA20 ($7.81), EMA50 ($7.55) and EMA200 ($6.07) as of the same reading. Spot has since moved below the EMA20 and EMA50, so the moving-average structure has weakened.

Chart Patterns

INJ broke out of a falling channel in recent sessions. Buyers stepped in at the $7.659 support zone on Nov 10, and a 4-hour candle broke the upper trendline of the channel. The rally then ran into the $8.433 resistance zone, where sellers cap rallies. The subsequent decline has pulled price back toward the broken channel and the trendline support.

Volume

The 24-hour volume of $96.41M equals about 14% of the $688.17M market capitalization, which points to active trading during the decline. Volume alone does not show whether buyers or sellers dominated, so the price action and momentum readings carry more weight.

Outlook

Short-term (hourly to daily): The $7.19 trendline and the $7.55 EMA are the key ceiling. Failure to reclaim them, together with falling daily RSI and a negative MACD histogram, favors a test of $6.71. Hourly momentum is the first gauge of a stabilization.

Medium-term (daily to weekly): The $6.07–$6.27 EMA200 zone is the main structural floor. Holding it preserves the longer-term uptrend, while a daily close below it would shift the structure toward bearish. A recovery above $8.15 would be needed to restore the near-term bullish setup.